C. Puccetti

508 total citations
17 papers, 220 citations indexed

About

C. Puccetti is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, C. Puccetti has authored 17 papers receiving a total of 220 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in C. Puccetti's work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Cancer Treatment and Pharmacology (4 papers). C. Puccetti is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Cancer Treatment and Pharmacology (4 papers). C. Puccetti collaborates with scholars based in Italy, Spain and France. C. Puccetti's co-authors include Andrea Camerini, D. Amoroso, Sara Donati, C. Valsuani, G. Tartarelli, Elisabetta Renzoni, Giorgio Giorgi, Cecilia Fondelli, Nicola Maurea and Maria Laura Canale and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

C. Puccetti

16 papers receiving 214 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Puccetti Italy 8 140 98 40 37 31 17 220
Grigorios Xepapadakis Greece 9 196 1.4× 38 0.4× 128 3.2× 64 1.7× 28 0.9× 24 333
Jacklyn N. Thibert United States 7 137 1.0× 41 0.4× 71 1.8× 60 1.6× 16 0.5× 9 336
Jigui Chen China 11 122 0.9× 39 0.4× 57 1.4× 78 2.1× 40 1.3× 18 261
Yizhen Liu China 11 64 0.5× 54 0.6× 54 1.4× 132 3.6× 56 1.8× 38 288
Robbert J. van Alphen Netherlands 10 132 0.9× 63 0.6× 36 0.9× 71 1.9× 11 0.4× 18 273
Meizhi He China 8 120 0.9× 67 0.7× 44 1.1× 100 2.7× 33 1.1× 12 324
Dong Gue Shin South Korea 7 61 0.4× 70 0.7× 99 2.5× 66 1.8× 36 1.2× 17 225
Tomoaki Mizobe Japan 11 181 1.3× 66 0.7× 47 1.2× 80 2.2× 30 1.0× 30 322
Nozomu Nakai Japan 9 150 1.1× 55 0.6× 33 0.8× 61 1.6× 14 0.5× 24 244

Countries citing papers authored by C. Puccetti

Since Specialization
Citations

This map shows the geographic impact of C. Puccetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Puccetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Puccetti more than expected).

Fields of papers citing papers by C. Puccetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Puccetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Puccetti. The network helps show where C. Puccetti may publish in the future.

Co-authorship network of co-authors of C. Puccetti

This figure shows the co-authorship network connecting the top 25 collaborators of C. Puccetti. A scholar is included among the top collaborators of C. Puccetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Puccetti. C. Puccetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Canale, Maria Laura, Giancarlo Casolo, Sara Donati, et al.. (2023). Baseline Troponin Level and Cardiac Toxicity in HER2-positive Early Breast Cancer Patients Receiving Trastuzumab. In Vivo. 37(5). 2139–2146.
2.
3.
Canale, Maria Laura, Andrea Camerini, Giancarlo Casolo, et al.. (2020). Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy. Advances in Therapy. 37(7). 3178–3184. 31 indexed citations
4.
Mencoboni, Manlio, Rosangela Filiberti, Alessandro Del Conte, et al.. (2017). Safety of First-line Chemotherapy with Metronomic Single-agent Oral Vinorelbine in Elderly Patients with NSCLC. Anticancer Research. 37(6). 3189–3194. 23 indexed citations
5.
Camerini, Andrea, Antonio Chella, Francesca Mazzoni, et al.. (2016). First-line treatment of NSCLC with bevacizumab: real world data from an Italian regional based survey. Journal of Chemotherapy. 29(1). 38–41. 1 indexed citations
6.
Camerini, Andrea, C. Puccetti, Sara Donati, et al.. (2015). Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial). BMC Cancer. 15(1). 359–359. 61 indexed citations
7.
Camerini, Andrea, C. Puccetti, Sara Donati, et al.. (2014). Phase Ii Trial of Metronomic Oral Vinorelbine As First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer (Move Trial). Annals of Oncology. 25. iv442–iv442. 1 indexed citations
8.
Camerini, Andrea, Sara Donati, Paolo Viacava, et al.. (2011). Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer. Journal of Experimental & Clinical Cancer Research. 30(1). 38–38. 13 indexed citations
9.
Camerini, Andrea, Ornella Garrone, C. Valsuani, et al.. (2009). Fulvestrant treatment is associated with cholesterol plasma level reduction in hormone receptor-positive metastatic breast cancer patients. Cancer Biology & Therapy. 8(15). 1450–1455. 2 indexed citations
10.
Camerini, Andrea, C. Valsuani, Francesca Mazzoni, et al.. (2009). Phase II trial of single-agent oral vinorelbine in elderly (≥70 years) patients with advanced non-small-cell lung cancer and poor performance status. Annals of Oncology. 21(6). 1290–1295. 18 indexed citations
11.
Valsuani, C., Andrea Camerini, Maria Laura Canale, et al.. (2009). Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: a case report. Cases Journal. 2(1). 9133–9133. 2 indexed citations
12.
Camerini, Andrea, Ornella Garrone, C. Valsuani, et al.. (2009). Effect of fulvestrant treatment on serum VEGF levels in hormone-sensitive metastatic breast cancer patients. Journal of Clinical Oncology. 27(15_suppl). 1124–1124. 1 indexed citations
13.
Amoroso, D., Sara Donati, C. Valsuani, et al.. (2009). Combination of trastuzumab, oxaliplatin, and docetaxel as first-line treatment in HER2-positive metastatic breast cancer patients: First-step results of a phase II trial (HOT trial). Journal of Clinical Oncology. 27(15_suppl). 1132–1132. 2 indexed citations
14.
Fondelli, Cecilia, et al.. (2002). Antioxidant effects of gliclazide, glibenclamide, and metformin in patients with type 2 diabetes mellitus. Current Therapeutic Research. 63(7). 411–420. 31 indexed citations
15.
Salvagno, Luigi, Mariella Sorarů, C. Puccetti, et al.. (1999). Gastric non-Hodgkin's lymphoma: analysis of 252 patients from a multicenter study.. PubMed. 85(2). 113–21. 14 indexed citations
16.
Salvagno, Luigi, Mariella Sorarů, C. Puccetti, et al.. (1999). Gastric non-Hodgkin's lymphomas: analysis of 252 patients. A multicenter study.. 85(2). 113–121. 1 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Grigorios Xepapadakis Breakdown of academic impact, for papers by Jacklyn N. Thibert Breakdown of academic impact, for papers by Jigui Chen Breakdown of academic impact, for papers by Yizhen Liu Breakdown of academic impact, for papers by Robbert J. van Alphen Breakdown of academic impact, for papers by Meizhi He Breakdown of academic impact, for papers by Dong Gue Shin Breakdown of academic impact, for papers by Tomoaki Mizobe Breakdown of academic impact, for papers by Nozomu Nakai
Rankless by CCL
2026